Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 78.5 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 150 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 158 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 101 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 95.5 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 129 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 56.4 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 73.6 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 0.0 | BCD100427B001 | 78 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 0.5 | BCD100427B003 | 85.9 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 1.0 | BCD100427B007 | 198 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 2.0 | BCD100427B011 | 88.2 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 4.0 | BCD100427B015 | 97.9 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 8.0 | BCD100427B019 | 57.5 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 12.0 | BCD100427B023 | 89.3 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | C | 24.0 | BCD100427B027 | 52.1 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 93.8 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 99.8 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 99.1 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 86.9 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 124 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 33.6 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 90.1 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 0.5 | BCD100427B004 | 168 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 1.0 | BCD100427B008 | 87.2 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 2.0 | BCD100427B012 | 201 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 4.0 | BCD100427B016 | 86.5 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 8.0 | BCD100427B020 | 58.4 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 12.0 | BCD100427B024 | 125 | pmol/sample |
| - | PE(34:1e)/PE(34:0p) | 25OH-Chol | 24.0 | BCD100427B028 | 39 | pmol/sample |